Guest
Guest
May 05, 2026
2:33 AM
|
There is no single organization that specifically “owns” or individually oversees clinical trials for Malegra Oral Jelly as a branded product. Instead, oversight depends on the regulatory system where the trials are conducted, because Malegra Oral Jelly is a generic sildenafil formulation (similar to Viagra) made by pharmaceutical manufacturers.
In India, where many such products are produced and tested, clinical trials are primarily regulated by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare. The CDSCO, through the Drugs Controller General of India (DCGI), is responsible for approving clinical trial applications, monitoring safety, and ensuring compliance with national drug laws.
Before any trial begins, it must also be reviewed and approved by an Independent Ethics Committee (IEC) or Institutional Ethics Committee. MALEGRA ORAL JELLY committees protect participant rights, ensure informed consent, and evaluate whether the study design is ethical and safe.
Additionally, scientific evaluation is often supported by Subject Expert Committees (SECs) under CDSCO, which review clinical data, dosage safety, and study methodology before recommending approval or modifications.
The actual trials are conducted by pharmaceutical companies and contract research organizations (CROs), but they must follow strict Good Clinical Practice (GCP) guidelines established internationally by bodies such as the World Health Organization (WHO) and ICH (International Council for Harmonisation).
|
